Denmark· DK-28106829022
Zomylac
A sulfamethoxazole and trimethoprim product containing sulfamethoxazol, trimethoprim, registered in Denmark by Macure Healthcare Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Sulfamethoxazole and trimethoprim is registered in 12 of 19 countries.
Countries holding a registration under ATC J01EE01 (sulfamethoxazole and trimethoprim), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Sulfamethoxazole and trimethoprim · ATC J01EE01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of sulfamethoxazole and trimethoprim costs, country by country.
Normalised to the WHO defined daily dose (1.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sulfamethoxazole and trimethoprim · price per daily dose (1.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.70
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- SULFAMETHOXAZOL, TRIMETHOPRIM
- Manufacturer
- Macure Healthcare Limited
- Country
- Denmark (DK)
- ATC code
- J01EE01
- ATC class
- Sulfamethoxazole and trimethoprim
- Defined daily dose
- 1.6 g, Sulfamethoxazol
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106829022
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
46 interactions on record for sulfamethoxazole and trimethoprim.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulfamethoxazole and trimethoprim · interactions on record
46 records
46 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under J01EE01
Sulfamethoxazole and trimethoprim, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed1cf120-65e7-4b5d-8524-5c6183376a08 GET /v1/drugs/ed1cf120-65e7-4b5d-8524-5c6183376a08?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "80+16 mg/ml",
"auth_role": "RMS",
"dk_drugid": "28106829022",
"substance": "SULFAMETHOXAZOL, TRIMETHOPRIM",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "45355"
}See everything about sulfamethoxazole and trimethoprim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.